The mRNA Technology Transfer Programme, jointly developed by WHO and MPP, was launched in July 2021 with the aim to build capacity in low- and middle-income countries (LMICs) ...
The recommendations issued are used by the national vaccine regulatory agencies and pharmaceutical companies to develop, produce, and license influenza vaccines for the following...
On January 31, 2020, the Secretary of the U.S. Department of Health & Human Services (HHS) declared a Public Health Emergency followed by the declaration of a National Emergency...